NEW YORK (CNN) - The acting Food and Drug Administration (FDA) commissioner on Monday disputed a published report that said agency officials knew before Oct. 5 that British health authorities might suspend the operating license of Chiron's vaccine plant in Liverpool. <snip>
The Washington Post reported over the weekend that British health officials said their U.S. counterparts were told last month that problems at the vaccine plant in England could affect supplies to the United States.
The newspaper said records from Britain's Department of Health show that Chiron "warned officials of the U.S. Food and Drug Administration and the British Medicines and Healthcare Products Regulatory Agency on Sept. 13 that potential contamination problems remained unresolved at the plant," the story said.
That account differs from those of U.S. health officials, who said the decision by Britain's health authorities to suspend production for three months because of contamination concerns at the plant surprised them. <snip>
http://money.cnn.com/2004/10/11/news/midcaps/chiron/